Sfoglia per RIVISTA
BLOOD ADVANCES
Collezione AOU Alessandria

  

Items : 14

Large clones of Clonal Hematopoiesis affect outcome in Mantle Cell Lymphoma: Results from The FIL MCL0208 Clinical Trial. in Blood advances / Blood Adv. 2025 Jan 14:bloodadvances.2024014948. doi: 10.1182/bloodadvances.2024014948.

2025
AOU Alessandria
AOU Città della Salute di Torino

da Silva MG; Zilioli VRR; Balzarotti M MD; Boccomini C; Postorino M; Merli M; Careddu MG; Lucchini E; Patti C; Palmas AD; Pascarella A; Michieli M; Vallisa D; Puccini B; Ballerini F; Stefoni V Dr; Cavallo F; Amaducci E; Evangelista A; Civita AM; Alessandria B; Gandossini M; Genuardi E; Ragaini S; Galli A; Bruno B; Rizzo E; Ladetto M; Malcovati L; et alii...

Clonal hematopoiesis in patients with autoimmune thrombocytopenia: an international multicenter study. in Blood advances / Blood Adv. 2024 Nov 13:bloodadvances.2024014984. doi: 10.1182/bloodadvances.2024014984.

2024
AOU Alessandria

Fattizzo B; Marchetti A; Bosi A; Gurnari C; Giannotta JA; Pedone GL; Rossi E; Carrai V; Guido A; Brioschi F; Carpenedo M; Crugnola M; Caramazza D; Leuzzi L; Marchetti M; Merati G; Malato S; Vianello F; Patriarca A; Awada H; Bortolotti M; Canzi M; Bolli N; Capecchi M; Chen F; Artoni A; Maciejewski JP; Barcellini W;

IELSG30 phase 2 trial: intravenous and intrathecal CNS prophylaxis in primary testicular diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2024 Mar 26;8(6):1541-1549. doi: 10.1182/bloodadvances.2023011251.

2024
AOU Alessandria
AOU Città della Salute di Torino

Dore F; Pinotti G; Pisani F; Ghiggi C; Zanni M; Annibali O; Liberati AM; Celli M; Cabras MG; Orsucci L; Bruna R; Tani M; Vanazzi A; Tucci A; Merli F; Balzarotti M; Gaidano G; Sassone M; Botto B; Stathis A; Ferreri AJM; Chiappella A; Conconi A; Esposito F; Pirosa MC; Cesaretti M; Bonomini L; Vitolo U; Zucca E; et alii...

Impact of SARS-CoV-2 vaccination and monoclonal antibodies on outcome post-CD19-directed CAR T-cell therapy: an EPICOVIDEHA survey. in Blood advances / Blood Adv. 2023 Jun 13;7(11):2645-2655. doi: 10.1182/bloodadvances.2022009578.

2023
AOU Alessandria

van Doesum JA; Salmanton-García J; Marchesi F; Di Blasi R; Falces-Romero I; Cabirta A; Farina F; Besson C; Weinbergerová B; Van Praet J; Schönlein M; López-García A; Lamure S; Guidetti A; De Ramón-Sánchez C; Batini? J; Gavriilaki E; Tragiannidis A; Tisi MC; Plantefeve G; Petzer V; Ormazabal-Vélez I; Marques de Almeida J; Marchetti M; Maertens J; Machado M; Kulasekararaj A; Hernández-Rivas JÁ; Gomes da Silva M; et alii...

Candidate germline biomarkers of lenalidomide efficacy in mantle cell lymphoma: the Fondazione Italiana Linfomi MCL0208 trial. in Blood advances / Blood Adv. 2023 Jul 25;7(14):3764-3774. doi: 10.1182/bloodadvances.2022009504.

2023
AOU Alessandria
AOU Città della Salute di Torino

Puccini B; Ferreri AJM; Ballerini F; Lucchini E; Arcaini L; Moita F; Zilioli V; Balzarotti M; Cavallo F; Boccomini C; Stefoni V; Re A; Di Rocco A; Tavarozzi R; Ghislieri M; De Luca G; Genuardi E; Alessandria B; Zaccaria GM; Pironti M; Arrigoni E; Grimaldi D; Ferrero S; Palumbo GA; Galimberti S; Cortelazzo S; Di Paolo A; Ladetto M;

A Fondazione Italiana Linfomi cohort study of R-COMP vs R-CHOP in older patients with diffuse large B-cell lymphoma. in Blood advances / Blood Adv. 2023 Aug 8;7(15):4160-4169. doi: 10.1182/bloodadvances.2023009839.

2023
AOU Alessandria
AOU Città della Salute di Torino

Cencini E; Ferrero S; Dessì D; Nassi L; Pagani C; Vallisa D; Merli M; Tani M; Di Rocco A; Flenghi L; Tarantini G; Hohaus S; Zanni M; Gini G; Botto B; Sartori R; Marino D; Musuraca G; Mahmoud AM; Zilioli VR; Pennese E; Luminari S; Pelliccia S; Balzarotti M; Fabbri A; Cavallo F; Usai SV; Puccini B; Tucci A; et alii...

Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL. in Blood advances / Blood Adv. 2023 Aug 8;7(15):3916-3924. doi: 10.1182/bloodadvances.2023009744.

2023
AOU Alessandria
AOU Città della Salute di Torino

Stelitano C; Quaglia FM; Pileri SA; Ferrante M; Bruna R; Sciarra R; Zanni M; Zambello R; Chini C; Ghiggi C; Di Rocco A; Cencini E; Puccini B; Celli M; Tani M; Botto B; Spina M; Ferrero S; Evangelista A; Patti C; Moia R; Tisi MC; Re A; Volpetti S; Zilioli VR; Arcari A; Merli F; Visco C;

COVID-19 and hairy-cell leukemia: an EPICOVIDEHA survey. in Blood advances / Blood Adv. 2022 Jul 12;6(13):3870-3874. doi: 10.1182/bloodadvances.2022007357.

2022
AOU Alessandria
AOU Città della Salute di Torino

Passamonti F; Pagliuca A; Koehler P; Klimko N; Corradini P; Hoenigl M; Busca A; Zompi S; Sacchi MV; Nunes Rodrigues R; Nordlander A; Essame J; Cordoba R; Batini? J; Bergantim R; Bilgin YM; Blennow O; Cattaneo C; Duarte RF; Emarah Z; Gomes da Silva M; González-López TJ; Kulasekararaj A; Ledoux MP; López-García A; Merelli M; Prezioso L; Ilhan O; Seval GC; et alii...

Relative dose intensity of obinutuzumab-chlorambucil in chronic lymphocytic leukemia: a multicenter Italian study. in Blood advances / Blood Adv. 2022 Jul 12;6(13):3875-3878. doi: 10.1182/bloodadvances.2022006964.

2022
AOU Alessandria
AOU Città della Salute di Torino

Trentin L; Angeletti I; Coscia M; Patti C; Sanna A; Murru R; Sapienza G; Cuccaro A; Marasca R; Sportoletti P; Morelli F; Chiarenza A; Vitale C; Moretti M; Tomasso A; Visentin A; Catania G; Piciocchi A; Autore F; Fresa A; Pietrasanta D; Innocenti I; Laurenti L;

A prognostic model for patients with lymphoma and COVID-19: a multicentre cohort study. in Blood advances / Blood Adv. 2022 Jan 11;6(1):327-338. doi: 10.1182/bloodadvances.2021005691.

2022
AOU Alessandria
AO Cuneo
AOU Città della Salute di Torino

Merli F; Krampera M; Corradini P; Passamonti F; Lanza F; Candoni A; Conconi A; Tosi P; Vallisa D; Venditti A; Selleri C; La Barbera EO; Gambacorti-Passerini C; Visani G; Rigacci L; Armiento D; Cilloni D; Corso A; Gherlinzoni F; Tafuri A; Galimberti S; Bocchia M; Cardinali V; Turrini M; Trentin L; Della Porta M; Scattolin A; Tisi MC; Cuneo A; et alii...

Role of radiotherapy to bulky sites of advanced Hodgkin lymphoma treated with ABVD: final results of FIL HD0801 trial. in Blood advances / Blood Adv. 2021 Nov 9;5(21):4504-4514. doi: 10.1182/bloodadvances.2021005150.

2021
AOU Alessandria
AOU Città della Salute di Torino

Botto B; Abruzzese E; Zaja F; Tani M; Simontacchi G; Rigacci L; Santoro A; Grapulin L; Pulsoni A; Frezza GP; Franzone P; Zanni M; Nassi L; Nardella A; Pavone V; Re A; Buglione M; Gotti M; Gioia DM; Sacchetti GM; Evangelista A; Levis M; Ricardi U; Zilioli VR; Rota-Scalabrini D; Freilone R; Ciccone G; Filippi AR; Zinzani PL; et alii...

Outcomes of older patients with follicular lymphoma using individual data from 5922 patients in 18 randomized controlled trials. in Blood advances / Blood Adv. 2021 Mar 23;5(6):1737-1745. doi: 10.1182/bloodadvances.2020002724.

2021
AOU Alessandria

Casulo C; Dixon JG; Ou FS; Hoster E; Peterson BA; Hochster HS; Brice P; Ladetto M; Hiddemann W; Marcus R; Kimby E; Herold M; Nielsen T; Morschhauser F; Rummel M; Hagenbeek A; Vitolo U; Salles GA; Shi Q; Flowers CR;

Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP. in Blood advances / Blood Adv. 2019 Dec 23;3(24):4280-4290. doi: 10.1182/bloodadvances.2019000865.

2019
AOU Alessandria
AOU Città della Salute di Torino

Rupoli S; Rege-Cambrin G; Rapezzi D; Pregno P; Palmieri F; Musolino C; Montefusco E; Melpignano A; Miggiano MC; Martino B; Marasca R; Malagola M; Lunghi M; Lunghi F; Luciano L; Lucchesi A; Levato L; La Barba G; Iurlo A; Gozzini A; Gugliotta G; Giai V; Galimberti S; Fozza C; Fazi P; Fava C; Elena C; D'Adda M; Crugnola M; et alii...

Randomized trial comparing standard vs sequential high-dose chemotherapy for inducing early CR in adult AML. in Blood advances / Blood Adv. 2019 Apr 9;3(7):1103-1117. doi: 10.1182/bloodadvances.2018026625.

2019
AOU Alessandria
AOU Città della Salute di Torino

Spinelli O; Oldani E; Zanghì P; Ferrero D; Cortelezzi A; Corradini P; Campiotti L; Todisco E; Scattolin AM; Bernardi M; Borlenghi E; Ciceri F; Cattaneo C; De Paoli L; Terruzzi E; Mattei D; Cavattoni I; Marmont F; Gianfaldoni G; Boschini C; Pavoni C; Masciulli A; Bassan R; Intermesoli T; Audisio E; Cortelazzo S; Bosi A; Falini B; Pogliani EM; et alii...